{
  "DOI": "10.1007/s10689-021-00259-9",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00259-9",
  "alternative-id": [
    "259"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "24 March 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "20 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "8 May 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Informed consent was obtained from all individuals included in the study."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Participants consented to publication of de-identified information on the consent to participate. Only de-identified information included."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "Approval was obtained from the Human Research Ethics Committee of Northern Sydney Local Health District. Approval was granted by the ethics committee on 18 June 2018: 2020ETH00762. The procedures used in this study adhere to the tenets of the Declaration of Helsinki."
    },
    {
      "label": "Free to read",
      "name": "free",
      "value": "This content has been made available to all."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-5578-0460",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Crook",
      "given": "Ashley",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kwa",
      "given": "Rebekah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ephraums",
      "given": "Sarah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wilding",
      "given": "Mathilda",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thiyagarajan",
      "given": "Lavvina",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1164-2386",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Fleming",
      "given": "Jane",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Moore",
      "given": "Katrina",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2495-4928",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Berman",
      "given": "Yemima",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        5,
        8
      ]
    ],
    "date-time": "2021-05-08T03:33:29Z",
    "timestamp": 1620444809000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        3,
        29
      ]
    ],
    "date-time": "2022-03-29T19:57:50Z",
    "timestamp": 1648583870000
  },
  "funder": [
    {
      "name": "Children's Tumour Foundation Grant"
    },
    {
      "name": "The honourable Brad Hazzard"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        29
      ]
    ],
    "date-time": "2023-09-29T15:34:44Z",
    "timestamp": 1696001684138
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2021,
        5,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2022,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            8
          ]
        ],
        "date-time": "2021-05-08T00:00:00Z",
        "timestamp": 1620432000000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            8
          ]
        ],
        "date-time": "2021-05-08T00:00:00Z",
        "timestamp": 1620432000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00259-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00259-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00259-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "241-253",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        5,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        5,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/bjc.2015.78",
      "author": "OO Seminog",
      "doi-asserted-by": "publisher",
      "first-page": "1546",
      "issue": "9",
      "journal-title": "Br J Cancer",
      "key": "259_CR1",
      "unstructured": "Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112(9):1546–1548. https://doi.org/10.1038/bjc.2015.78",
      "volume": "112",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s13053-019-0110-z",
      "author": "LP Suarez-Kelly",
      "doi-asserted-by": "publisher",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "259_CR2",
      "unstructured": "Suarez-Kelly LP, Yu L, Kline D, Schneider EB, Agnese DM, Carson WE (2019) Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature. Hered Cancer Clin Pract. https://doi.org/10.1186/s13053-019-0110-z",
      "year": "2019"
    },
    {
      "DOI": "10.1038/bjc.2016.403",
      "author": "E Uusitalo",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "259_CR3",
      "unstructured": "Uusitalo E, Kallionpaa RA, Kurki S et al (2017) Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer 116(2):211–217. https://doi.org/10.1038/bjc.2016.403",
      "volume": "116",
      "year": "2017"
    },
    {
      "DOI": "10.6004/jnccn.2017.0003",
      "author": "MB Daly",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "issue": "1",
      "journal-title": "J Natl Compr Canc Netw",
      "key": "259_CR4",
      "unstructured": "Daly MB, Pilarski R, Berry M et al (2017) NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: breast and ovarian, version 2.2017. J Natl Compr Canc Netw 15(1):9–20. https://doi.org/10.6004/jnccn.2017.0003",
      "volume": "15",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2018.28",
      "author": "DR Stewart",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "259_CR5",
      "unstructured": "Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 20(7):671–682. https://doi.org/10.1038/gim.2018.28",
      "volume": "20",
      "year": "2018"
    },
    {
      "key": "259_CR6",
      "unstructured": "NSW Cancer Institute (2020) NF1 (Neurofibromatosis type 1)—risk management. vol. 14/11, NSW Government, https://eviq.org.au/cancer-genetics/adult/risk-management/752-nf1-neurofibromatosis-type-1-risk-manageme. Accessed 3 Dec 2020"
    },
    {
      "DOI": "10.1136/jmg.2006.045906",
      "author": "RE Ferner",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "issue": "2",
      "journal-title": "J Med Genet",
      "key": "259_CR7",
      "unstructured": "Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44(2):81–88. https://doi.org/10.1136/jmg.2006.045906",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.a.35550",
      "author": "SA Madanikia",
      "doi-asserted-by": "publisher",
      "first-page": "3056",
      "issue": "12",
      "journal-title": "Am J Med Genet A",
      "key": "259_CR8",
      "unstructured": "Madanikia SA, Bergner A, Ye X, Blakeley JON (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158(12):3056–3060. https://doi.org/10.1002/ajmg.a.35550",
      "volume": "158",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2015.65.3576",
      "author": "E Uusitalo",
      "doi-asserted-by": "publisher",
      "first-page": "1978",
      "issue": "17",
      "journal-title": "J Clin Oncol",
      "key": "259_CR9",
      "unstructured": "Uusitalo E, Rantanen M, Kallionpää RA et al (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34(17):1978–1986. https://doi.org/10.1200/JCO.2015.65.3576",
      "volume": "34",
      "year": "2016"
    },
    {
      "author": "DF Easton",
      "first-page": "305",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "259_CR10",
      "unstructured": "Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53(2):305–313",
      "volume": "53",
      "year": "1993"
    },
    {
      "DOI": "10.1001/archneur.1988.00520290115023",
      "doi-asserted-by": "crossref",
      "key": "259_CR11",
      "unstructured": "(1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45(5):575–578. https://pubmed.ncbi.nlm.nih.gov/3128965/"
    },
    {
      "DOI": "10.1007/s10897-015-9829-5",
      "author": "H Crawford",
      "doi-asserted-by": "publisher",
      "first-page": "931",
      "issue": "6",
      "journal-title": "J Genet Couns",
      "key": "259_CR12",
      "unstructured": "Crawford H, Barton B, Wilson M et al (2015) The impact of neurofibromatosis type 1 on the health and wellbeing of Australian adults. J Genet Couns 24(6):931–944. https://doi.org/10.1007/s10897-015-9829-5",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S1474-4422(14)70063-8",
      "author": "AC Hirbe",
      "doi-asserted-by": "publisher",
      "first-page": "834",
      "issue": "8",
      "journal-title": "Lancet Neurol",
      "key": "259_CR13",
      "unstructured": "Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13(8):834–843. https://doi.org/10.1016/S1474-4422(14)70063-8",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1177/1087054711433422",
      "author": "AK Templer",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "issue": "6",
      "journal-title": "J Atten Disord",
      "key": "259_CR14",
      "unstructured": "Templer AK, Titus JB, Gutmann DH (2013) A neuropsychological perspective on attention problems in neurofibromatosis type 1. J Atten Disord 17(6):489–496. https://doi.org/10.1177/1087054711433422",
      "volume": "17",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12955-017-0607-y",
      "author": "R Ferner",
      "doi-asserted-by": "publisher",
      "journal-title": "Health Qual Life Outcomes",
      "key": "259_CR15",
      "unstructured": "Ferner R, Thomas M, Mercer G et al (2017) Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-017-0607-y",
      "year": "2017"
    },
    {
      "DOI": "10.1007/978-0-85729-629-0",
      "author": "RE Ferner",
      "doi-asserted-by": "publisher",
      "key": "259_CR16",
      "unstructured": "Ferner RE (2011) Neurofibromatoses in clinical practice. Springer, London",
      "volume-title": "Neurofibromatoses in clinical practice",
      "year": "2011"
    },
    {
      "DOI": "10.1159/000337548",
      "author": "S Granström",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "issue": "2",
      "journal-title": "Dermatology",
      "key": "259_CR17",
      "unstructured": "Granström S, Langenbruch A, Augustin M, Mautner V-F (2012) Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image. Dermatology 224(2):160–167. https://doi.org/10.1159/000337548",
      "volume": "224",
      "year": "2012"
    },
    {
      "DOI": "10.1111/cge.12551",
      "author": "JS Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "425",
      "issue": "5",
      "journal-title": "Clin Genet",
      "key": "259_CR18",
      "unstructured": "Cohen JS, Levy HP, Sloan J, Dariotis J, Biesecker BB (2015) Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet 88(5):425–430. https://doi.org/10.1111/cge.12551",
      "volume": "88",
      "year": "2015"
    },
    {
      "DOI": "10.1016/0022-510X(96)00022-6",
      "author": "RE Ferner",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "issue": "1–2",
      "journal-title": "J Neurol Sci",
      "key": "259_CR19",
      "unstructured": "Ferner RE, Hughes RAC, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138(1–2):125–133. https://doi.org/10.1016/0022-510X(96)00022-6",
      "volume": "138",
      "year": "1996"
    },
    {
      "DOI": "10.1186/s12883-019-1338-y",
      "author": "A Sanagoo",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Neurol",
      "key": "259_CR20",
      "unstructured": "Sanagoo A, Jouybari L, Koohi F, Sayehmiri F (2019) Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study. (Report). BMC Neurol. https://doi.org/10.1186/s12883-019-1338-y",
      "year": "2019"
    },
    {
      "DOI": "10.1093/noajnl/vdaa003",
      "author": "G Hamoy-Jimenez",
      "doi-asserted-by": "publisher",
      "first-page": "i141",
      "issue": "Supplement_1",
      "journal-title": "Neuro-Oncol Adv",
      "key": "259_CR21",
      "unstructured": "Hamoy-Jimenez G, Kim R, Suppiah S, Zadeh G, Bril V, Barnett C (2020) Quality of life in patients with neurofibromatosis type 1 and 2 in Canada. Neuro-Oncol Adv 2(Supplement_1):i141–i149. https://doi.org/10.1093/noajnl/vdaa003",
      "volume": "2",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmg.2007.049346",
      "author": "S Sharif",
      "doi-asserted-by": "publisher",
      "first-page": "481",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "259_CR22",
      "unstructured": "Sharif S, Moran A, Huson SM et al (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481. https://doi.org/10.1136/jmg.2007.049346",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.3171/2009.11.Focus09221",
      "author": "ON Gottfried",
      "doi-asserted-by": "publisher",
      "first-page": "E8",
      "issue": "1",
      "journal-title": "Neurosurg Focus",
      "key": "259_CR23",
      "unstructured": "Gottfried ON, Viskochil DH, Couldwell WT (2010) Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus 28(1):E8. https://doi.org/10.3171/2009.11.Focus09221",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.4103/0973-1482.196761",
      "author": "D Pradhan",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "issue": "3",
      "journal-title": "J Cancer Res Ther",
      "key": "259_CR24",
      "unstructured": "Pradhan D, Kaur N, Gami A, Hura KS, Garg G, Mohanty SK (2017) Neurofibromatosis and breast cancer: do we need to revise the mammographic screening schedule in patients of neurofibromatosis? J Cancer Res Ther 13(3):583–585. https://doi.org/10.4103/0973-1482.196761",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-018-4851-6",
      "author": "YS Yap",
      "doi-asserted-by": "publisher",
      "first-page": "719",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "259_CR25",
      "unstructured": "Yap YS, Munusamy P, Lim C et al (2018) Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype. Breast Cancer Res Treat 171(3):719–735. https://doi.org/10.1007/s10549-018-4851-6",
      "volume": "171",
      "year": "2018"
    },
    {
      "DOI": "10.3390/cancers11050707",
      "author": "N Maani",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancers (Basel)",
      "key": "259_CR26",
      "unstructured": "Maani N, Westergard S, Yang J et al (2019) NF1 patients receiving breast cancer screening: insights from the Ontario High Risk Breast Screening Program. Cancers (Basel). https://doi.org/10.3390/cancers11050707",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41436-019-0651-6",
      "author": "DGR Evans",
      "doi-asserted-by": "publisher",
      "first-page": "398",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "259_CR27",
      "unstructured": "Evans DGR, Kallionpaa RA, Clementi M et al (2020) Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genet Med 22(2):398–406. https://doi.org/10.1038/s41436-019-0651-6",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12885-015-1215-z",
      "author": "AV Da Silva",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "259_CR28",
      "unstructured": "Da Silva AV, Rodrigues FR, Pureza M, Lopes VGS, Cunha KS (2015) Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer 15(1):183. https://doi.org/10.1186/s12885-015-1215-z",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2011.113",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1187",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "259_CR29",
      "unstructured": "Evans DG, O’Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19(11):1187–1191. https://doi.org/10.1038/ejhg.2011.113",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1111/cge.12627",
      "author": "HA Crawford",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "issue": "3",
      "journal-title": "Clin Genet",
      "key": "259_CR30",
      "unstructured": "Crawford HA, Barton B, Wilson MJ et al (2016) Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care. Clin Genet 89(3):385–391. https://doi.org/10.1111/cge.12627",
      "volume": "89",
      "year": "2016"
    },
    {
      "DOI": "10.1377/hlthaff.2012.1061",
      "author": "J Hibbard",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Health Aff",
      "key": "259_CR31",
      "unstructured": "Hibbard J, Greene J (2013) What the evidence shows about patient activation: better health outcomes and care experiences; Fewer data on costs. Health Aff 32:207–214",
      "volume": "32",
      "year": "2013"
    },
    {
      "DOI": "10.7326/M15-0970",
      "author": "HD Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "issue": "4",
      "journal-title": "Ann Intern Med",
      "key": "259_CR32",
      "unstructured": "Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L (2016) Harms of breast cancer screening: systematic review to update the 2009 US Preventive Services Task Force Recommendation. Ann Intern Med 164(4):256. https://doi.org/10.7326/M15-0970",
      "volume": "164",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jech.51.6.705",
      "author": "W Scaf-Klomp",
      "doi-asserted-by": "publisher",
      "first-page": "705",
      "issue": "6",
      "journal-title": "J Epidemiol Community Health",
      "key": "259_CR33",
      "unstructured": "Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van Den Heuvel WJ (1997) Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 51(6):705. https://doi.org/10.1136/jech.51.6.705",
      "volume": "51",
      "year": "1997"
    },
    {
      "DOI": "10.1002/pon.1355",
      "author": "K Brain",
      "doi-asserted-by": "publisher",
      "first-page": "1180",
      "issue": "12",
      "journal-title": "Psychooncology",
      "key": "259_CR34",
      "unstructured": "Brain K, Henderson BJ, Tyndel S et al (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 17(12):1180–1188. https://doi.org/10.1002/pon.1355",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(12)61611-0",
      "author": "Independent Uk Panel On Breast Cancer S",
      "doi-asserted-by": "publisher",
      "first-page": "1778",
      "issue": "9855",
      "journal-title": "The Lancet",
      "key": "259_CR35",
      "unstructured": "Independent Uk Panel On Breast Cancer S (2012) The benefits and harms of breast cancer screening: an independent review. The Lancet 380(9855):1778–1786. https://doi.org/10.1016/S0140-6736(12)61611-0",
      "volume": "380",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ejca.2005.03.020",
      "author": "S van Dooren",
      "doi-asserted-by": "publisher",
      "first-page": "1416",
      "issue": "10",
      "journal-title": "Eur J Cancer",
      "key": "259_CR36",
      "unstructured": "van Dooren S, Seynaeve C, Rijnsburger AJ et al (2005) Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer. Eur J Cancer 41(10):1416–1425. https://doi.org/10.1016/j.ejca.2005.03.020",
      "volume": "41",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/84.1.24",
      "author": "KM Kash",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "issue": "1",
      "journal-title": "J Natl Cancer Inst",
      "key": "259_CR37",
      "unstructured": "Kash KM, Holland JC, Halper MS, Miller DG (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84(1):24–30. https://doi.org/10.1093/jnci/84.1.24",
      "volume": "84",
      "year": "1992"
    },
    {
      "DOI": "10.1038/sj.bjc.6601912",
      "author": "AJ Rijnsburger",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "1",
      "journal-title": "Br J Cancer",
      "key": "259_CR38",
      "unstructured": "Rijnsburger AJ, Essink-Bot ML, van Dooren S et al (2004) Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 91(1):69–76. https://doi.org/10.1038/sj.bjc.6601912",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.breast.2011.04.004",
      "author": "TN Spiegel",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "issue": "5",
      "journal-title": "Breast",
      "key": "259_CR39",
      "unstructured": "Spiegel TN, Esplen MJ, Hill KA, Wong J, Causer PA, Warner E (2011) Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance. Breast 20(5):424–430. https://doi.org/10.1016/j.breast.2011.04.004",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1038/bjc.2011.1",
      "author": "J Hutton",
      "doi-asserted-by": "publisher",
      "first-page": "578",
      "issue": "4",
      "journal-title": "Br J Cancer",
      "key": "259_CR40",
      "unstructured": "Hutton J, Walker LG, Gilbert FJ et al (2011) Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study. Br J Cancer 104(4):578–586. https://doi.org/10.1038/bjc.2011.1",
      "volume": "104",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.canep.2010.07.012",
      "author": "N Pashayan",
      "doi-asserted-by": "publisher",
      "first-page": "139",
      "issue": "2",
      "journal-title": "Cancer Epidemiol",
      "key": "259_CR41",
      "unstructured": "Pashayan N, Pharoah P, Tabár L et al (2011) Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. Cancer Epidemiol 35(2):139–144. https://doi.org/10.1016/j.canep.2010.07.012",
      "volume": "35",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7991",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "222",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "259_CR42",
      "unstructured": "Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28(2):222–231. https://doi.org/10.1200/JCO.2009.22.7991",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ijc.29534",
      "author": "S Saadatmand",
      "doi-asserted-by": "publisher",
      "first-page": "1729",
      "issue": "7",
      "journal-title": "Int J Cancer",
      "key": "259_CR43",
      "unstructured": "Saadatmand S, Obdeijn IM, Rutgers EJ et al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). Int J Cancer 137(7):1729–1738. https://doi.org/10.1002/ijc.29534",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s13053-016-0048-3",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "259_CR44",
      "unstructured": "Evans DG, Harkness EF, Howell A et al (2016) Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. Hered Cancer Clin Pract. https://doi.org/10.1186/s13053-016-0048-3",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jama.292.11.1317",
      "author": "E Warner",
      "doi-asserted-by": "publisher",
      "first-page": "1317",
      "issue": "11",
      "journal-title": "JAMA",
      "key": "259_CR45",
      "unstructured": "Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317–1325. https://doi.org/10.1001/jama.292.11.1317",
      "volume": "292",
      "year": "2004"
    },
    {
      "DOI": "10.1002/(SICI)1099-1611(199609)5:3\u003c259::AID-PON204\u003e3.0.CO;2-O",
      "author": "P Gagnon",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "issue": "3",
      "journal-title": "Psychooncology",
      "key": "259_CR46",
      "unstructured": "Gagnon P, Massie MJ, Kash KM et al (1996) Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psychooncology 5(3):259–269. https://doi.org/10.1002/(SICI)1099-1611(199609)5:3%3c259::AID-PON204%3e3.0.CO;2-O",
      "volume": "5",
      "year": "1996"
    },
    {
      "DOI": "10.1007/s10689-008-9182-z",
      "author": "J Reichelt",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "3",
      "journal-title": "Fam Cancer",
      "key": "259_CR47",
      "unstructured": "Reichelt J, Møller P, Heimdal K, Dahl A (2008) Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer. Fam Cancer 7(3):245–254. https://doi.org/10.1007/s10689-008-9182-z",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1002/pon.4047",
      "author": "IC Konings",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "issue": "8",
      "journal-title": "Psychooncology",
      "key": "259_CR48",
      "unstructured": "Konings IC, Sidharta GN, Harinck F et al (2016) Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology 25(8):971–978. https://doi.org/10.1002/pon.4047",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1600-0447.1983.tb09716.x",
      "author": "AS Zigmond",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "issue": "6",
      "journal-title": "Acta Psychiatr Scand",
      "key": "259_CR49",
      "unstructured": "Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x",
      "volume": "67",
      "year": "1983"
    },
    {
      "DOI": "10.1111/j.2044-8260.1992.tb00997.x",
      "author": "TM Marteau",
      "doi-asserted-by": "publisher",
      "first-page": "301",
      "issue": "3",
      "journal-title": "Br J Clin Psychol",
      "key": "259_CR50",
      "unstructured": "Marteau TM, Bekker H (1992) The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 31(3):301–306. https://doi.org/10.1111/j.2044-8260.1992.tb00997.x",
      "volume": "31",
      "year": "1992"
    },
    {
      "author": "C Spielberger",
      "key": "259_CR51",
      "unstructured": "Spielberger C, Gorusch R, Lushene R (1970) Manual for the State-Trait anxiety. Consulting Psychologists Press, California",
      "volume-title": "Manual for the State-Trait anxiety",
      "year": "1970"
    },
    {
      "author": "C Spielberger",
      "key": "259_CR52",
      "unstructured": "Spielberger C, Gorusch R, Lushene R (1983) Manual for the State-Trait anxiety inventory—form Y. Consulting Psychologists Press, Palo Alto, CA",
      "volume-title": "Manual for the State-Trait anxiety inventory—form Y",
      "year": "1983"
    },
    {
      "DOI": "10.1097/NCC.0b013e3182813a17",
      "author": "EJA Custers",
      "doi-asserted-by": "publisher",
      "first-page": "E44",
      "issue": "1",
      "journal-title": "Cancer Nurs",
      "key": "259_CR53",
      "unstructured": "Custers EJA, Van Den Berg WS, Van Laarhoven MHW, Bleiker AEM, Gielissen MMF, Prins BJ (2014) The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 37(1):E44–E50. https://doi.org/10.1097/NCC.0b013e3182813a17",
      "volume": "37",
      "year": "2014"
    },
    {
      "DOI": "10.1002/pon.1570",
      "author": "KF Douma",
      "doi-asserted-by": "publisher",
      "first-page": "289",
      "issue": "3",
      "journal-title": "Psychooncology",
      "key": "259_CR54",
      "unstructured": "Douma KF, Aaronson NK, Vasen HF et al (2010) Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology 19(3):289–298. https://doi.org/10.1002/pon.1570",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1002/pon.2960030406",
      "author": "DLG Walker",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "journal-title": "Psychooncology",
      "key": "259_CR55",
      "unstructured": "Walker DLG, Cordiner CM, Gilbert FJ et al (1994) How distressing is attendance for routine breast screening? Psychooncology 3:229–304. https://doi.org/10.1002/pon.2960030406",
      "volume": "3",
      "year": "1994"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.1968",
      "author": "ML Ballinger",
      "doi-asserted-by": "publisher",
      "first-page": "1634",
      "issue": "12",
      "journal-title": "JAMA Oncol",
      "key": "259_CR56",
      "unstructured": "Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3(12):1634–1639. https://doi.org/10.1001/jamaoncol.2017.1968",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jbi.2008.08.010",
      "author": "PA Harris",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "issue": "2",
      "journal-title": "J Biomed Inform",
      "key": "259_CR57",
      "unstructured": "Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010",
      "volume": "42",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-008-0140-0",
      "author": "S O’Neill",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "259_CR58",
      "unstructured": "O’Neill S, Rubinstein W, Sener S et al (2009) Psychological impact of recall in high-risk breast MRI screening. Breast Cancer Res Treat 115(2):365–371. https://doi.org/10.1007/s10549-008-0140-0",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1111/bju.14412",
      "author": "EK Bancroft",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "issue": "2",
      "journal-title": "BJU Int",
      "key": "259_CR59",
      "unstructured": "Bancroft EK, Saya S, Page EC et al (2019) Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. BJU Int 123(2):284–292. https://doi.org/10.1111/bju.14412",
      "volume": "123",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-016-9964-7",
      "author": "KA McBride",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "3",
      "journal-title": "Fam Cancer",
      "key": "259_CR60",
      "unstructured": "McBride KA, Ballinger ML, Schlub TE et al (2017) Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Fam Cancer 16(3):423–432. https://doi.org/10.1007/s10689-016-9964-7",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2012.85",
      "author": "LW Daphne",
      "doi-asserted-by": "publisher",
      "first-page": "977",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "259_CR61",
      "unstructured": "Daphne LW, Kelly BS, Sonia E et al (2012) Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 14(12):977. https://doi.org/10.1038/gim.2012.85",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.a.61627",
      "author": "K Doser",
      "doi-asserted-by": "publisher",
      "first-page": "1704",
      "issue": "7",
      "journal-title": "Am J Med Genet A",
      "key": "259_CR62",
      "unstructured": "Doser K, Andersen EW, Kenborg L et al (2020) Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: a nationwide study. Am J Med Genet A 182(7):1704–1715. https://doi.org/10.1002/ajmg.a.61627",
      "volume": "182",
      "year": "2020"
    },
    {
      "DOI": "10.1186/1477-7525-11-21",
      "author": "K Nutakki",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "journal-title": "Health Qual Life Outcomes",
      "key": "259_CR63",
      "unstructured": "Nutakki K, Hingtgen CM, Monahan P, Varni JW, Swigonski NL (2013) Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity. Health Qual Life Outcomes 11:21. https://doi.org/10.1186/1477-7525-11-21",
      "volume": "11",
      "year": "2013"
    },
    {
      "DOI": "10.1001/archderm.137.11.1421",
      "author": "P Wolkenstein",
      "doi-asserted-by": "publisher",
      "first-page": "1421",
      "issue": "11",
      "journal-title": "Arch Dermatol",
      "key": "259_CR64",
      "unstructured": "Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A (2001) Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 137(11):1421–1425. https://doi.org/10.1001/archderm.137.11.1421",
      "volume": "137",
      "year": "2001"
    },
    {
      "DOI": "10.1159/000187594",
      "author": "Y Kodra",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "issue": "3",
      "journal-title": "Dermatology",
      "key": "259_CR65",
      "unstructured": "Kodra Y, Giustini S, Divona L et al (2009) Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology 218(3):215–220. https://doi.org/10.1159/000187594",
      "volume": "218",
      "year": "2009"
    },
    {
      "DOI": "10.1002/ajmg.a.31422",
      "author": "PZ Page",
      "doi-asserted-by": "publisher",
      "first-page": "1893",
      "issue": "18",
      "journal-title": "Am J Med Genet A",
      "key": "259_CR66",
      "unstructured": "Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P (2006) Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Am J Med Genet A 140(18):1893–1898. https://doi.org/10.1002/ajmg.a.31422",
      "volume": "140",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106407",
      "author": "EK Bancroft",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "issue": "4",
      "journal-title": "J Med Genet",
      "key": "259_CR67",
      "unstructured": "Bancroft EK, Saya S, Brown E et al (2020) Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). J Med Genet 57(4):226–236. https://doi.org/10.1136/jmedgenet-2019-106407",
      "volume": "57",
      "year": "2020"
    },
    {
      "DOI": "10.1016/s0959-8049(98)00294-9",
      "author": "FJ Gilbert",
      "doi-asserted-by": "publisher",
      "first-page": "2010",
      "issue": "13",
      "journal-title": "Eur J Cancer",
      "key": "259_CR68",
      "unstructured": "Gilbert FJ, Cordiner CM, Affleck IR, Hood DB, Mathieson D, Walker LG (1998) Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. Eur J Cancer 34(13):2010–2014. https://doi.org/10.1016/s0959-8049(98)00294-9",
      "volume": "34",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.1991.9.7.1275",
      "author": "C Lerman",
      "doi-asserted-by": "publisher",
      "first-page": "1275",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "259_CR69",
      "unstructured": "Lerman C, Rimer BK, Engstrom PF (1991) Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 9(7):1275–1282. https://doi.org/10.1200/JCO.1991.9.7.1275",
      "volume": "9",
      "year": "1991"
    },
    {
      "DOI": "10.1177/104973239600600207",
      "author": "K Chalmers",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "issue": "2",
      "journal-title": "Qual Health Res",
      "key": "259_CR70",
      "unstructured": "Chalmers K, Thomson K (1996) Coming to terms with the risk of breast cancer: perceptions of women with primary relatives with breast cancer. Qual Health Res 6(2):256–282. https://doi.org/10.1177/104973239600600207",
      "volume": "6",
      "year": "1996"
    },
    {
      "DOI": "10.1177/1049732314529666",
      "author": "S Hesse-Biber",
      "doi-asserted-by": "publisher",
      "first-page": "773",
      "issue": "6",
      "journal-title": "Qual Health Res",
      "key": "259_CR71",
      "unstructured": "Hesse-Biber S (2014) The genetic testing experience of BRCA-positive women: deciding between surveillance and surgery. Qual Health Res 24(6):773–789. https://doi.org/10.1177/1049732314529666",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cncr.33004",
      "author": "N Rippinger",
      "doi-asserted-by": "publisher",
      "first-page": "4032",
      "issue": "17",
      "journal-title": "Cancer",
      "key": "259_CR72",
      "unstructured": "Rippinger N, Fischer C, Haun MW et al (2020) Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: a multicenter feasibility and acceptance survey. Cancer 126(17):4032–4041. https://doi.org/10.1002/cncr.33004",
      "volume": "126",
      "year": "2020"
    },
    {
      "DOI": "10.1136/eb-2012-100608",
      "author": "M Bond",
      "doi-asserted-by": "publisher",
      "first-page": "54",
      "issue": "2",
      "journal-title": "Evid Based Med",
      "key": "259_CR73",
      "unstructured": "Bond M, Pavey T, Welch K et al (2013) Psychological consequences of false-positive screening mammograms in the UK. Evid Based Med 18(2):54–61. https://doi.org/10.1136/eb-2012-100608",
      "volume": "18",
      "year": "2013"
    },
    {
      "DOI": "10.1136/bmjopen-2020-042696",
      "author": "K Hammarberg",
      "doi-asserted-by": "publisher",
      "first-page": "e042696",
      "issue": "11",
      "journal-title": "BMJ Open",
      "key": "259_CR74",
      "unstructured": "Hammarberg K, Tran T, Kirkman M, Fisher J (2020) Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey. BMJ Open 10(11):e042696. https://doi.org/10.1136/bmjopen-2020-042696",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.invent.2020.100351",
      "author": "L Staples",
      "doi-asserted-by": "publisher",
      "first-page": "100351",
      "journal-title": "Internet Interv",
      "key": "259_CR75",
      "unstructured": "Staples L, Nielssen O, Kayrouz R et al (2020) Rapid report 2: symptoms of anxiety and depression during the first 12 weeks of the Coronavirus (COVID-19) pandemic in Australia. Internet Interv 22:100351. https://doi.org/10.1016/j.invent.2020.100351",
      "volume": "22",
      "year": "2020"
    }
  ],
  "reference-count": 75,
  "references-count": 75,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00259-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}